Advanced Enzyme Technologies
ADVENZYMES · Pharma > Pharmaceuticals & Drugs · Chairman: Vasant Rathi Listing date: Aug. 2, 2016 · Employees: 750 · Thane · http://www.advancedenzymes.com

Stock Price vs Company Growth
1d
1.6%
1w
0.1%
1m
3.0%
3m
1.8%
6m
2.2%
1y
23.0%
5y
20.1%
all
6.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

374 1.6%
333
409
Company Overview

Sales
624 Cr
Growth: 11.4%
Profit after Tax
133 Cr
Growth: -2.8%
Small Cap
4,183 Cr
P/E: 31.2x
Industry P/E: 36.1x
Fundamentals

Sales (Cr) ₹ 624
Growth 11.4%
EBITDA 32.8%
P/S 6.7x
Dividend 1.7%
P/E 31.2x
Book Value ₹ 118
PEG Ratio 2.8x
ROE 10.2%
P/B 3.2x
Shareholding Pattern

Institutions
Orbimed Asia Iii Mauritius Limited
9.89 %
Nalanda India Equity Fund Limited
4.74 %
Hdfc Small Cap Fund
4.39 %
Orbimed Asia Iii Mauritius Fvci Limited
2.2 %
Icici Prudential Esg Fund
2.14 %
Promoters
Vasant Rathi
32.72 %
Advanced Vital Enzymes Private Limited
8.91 %
Reshma Namita Rathi
2.37 %
Rasika Vasant Rathi
2.36 %
Rachana Vasant Rathi
2.36 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes.
Investors (84)
Followers (13)